Contineum Therapeutics, Inc. (CTNM) stock
CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.86+0.08 (+0.82%)
Close on Nov 13, 2026Market cap $370.94MP/E –Yield –
Contineum Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Contineum Therapeutics's enterprise value was $123.71M on Nov 11, 2026, against $110.24M a year earlier. Over the last 3 years it ranged from -$125.26M to $306.71M, with a median of $77.54M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $123.71M | +3.3% |
| 2025 | Dec 31, 2025 | $119.76M | – |
| 2024 | Dec 31, 2024 | -$13.57M | – |
See a number that looks wrong?